Yayınlar & Eserler

Yayın Ağı
Makaleler 5
Tümü (5)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)

1. Baseline and three-month De Ritis ratio and gamma-glutamyltransferase as prognostic biomarkers in metastatic renal cell carcinoma treated with targeted therapy

AKTEPE O. H., ULAŞLI T., ÜNEK İ. T., ATAĞ AKYÜREK E., SEMİZ H. S., KARAOĞLU A., et al.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Elevated B12/CRP Index as a Simple Prognostic Indicator in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Targeted Therapy

Aktepe O. H., Ulasli T., Butun O., Yalcin S.
BIOMEDICINES , cilt.14, sa.5, 2026 (SCI-Expanded, Scopus)

3. Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy

AKTEPE O. H., Izgor R. B., ULAŞLI T., ÜNEK İ. T., Atag E., SEMİZ H. S., et al.
DISCOVER ONCOLOGY , cilt.17, sa.1, 2026 (SCI-Expanded, Scopus)

4. Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma

Aktepe O. H., Ulasli T., Terzi A., Gundogdu F., Yildirim E. C., Arslan A. M., et al.
Medicina (Lithuania) , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus)

5. Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

Aktepe O. H., Erdemır A. G., Yildirim E. C., Demirciler E., Ulasli T., Guven D. C., et al.
JOURNAL OF CLINICAL MEDICINE , cilt.14, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma
Metrikler

Yayın

5

Yayın (WoS)

5

Yayın (Scopus)

5

Atıf (WoS)

2

H-İndeks (WoS)

1

Atıf (Scopus)

2

H-İndeks (Scopus)

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER